A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE
- 29 February 2008
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 126 (2) , 189-201
- https://doi.org/10.1016/j.clim.2007.10.004
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cellsBlood, 2005
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- Expansion of CD19CD21 B Cells in Common Variable Immunodeficiency (CVID) Patients with Autoimmune CytopeniaImmunobiology, 2002
- A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell MovementsThe Journal of Experimental Medicine, 2001
- CD19-dependent Activation of Akt Kinase in B-lymphocytesJournal of Biological Chemistry, 2001
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localizationEuropean Journal of Immunology, 1998
- Positive and negative roles of the tyrosine kinase Lyn in B cell functionSeminars in Immunology, 1998
- The CD19–CD21 Complex Regulates Signal Transduction Thresholds Governing Humoral Immunity and AutoimmunityImmunity, 1997
- The CD19/CD21 signal transduction complex of B lymphocytesImmunology Today, 1994